NIH-funded research R37 grant

Understanding how leukemia stem cells grow and resist treatment

Official title: Regulation of Protein Synthesis in Leukemia Stem Cells

Funded at Ut Southwestern Medical Center · NIH-10932968 · Data updated 2026-11-12

This study is looking at how certain leukemia stem cells survive and resist treatment in acute myeloid leukemia, especially focusing on their need for protein production, to find new ways to help patients by targeting these cells more effectively.

More Leukemia research and trials

Quick facts

Grant typeR37 grant
Study typeNIH-funded research
Funding institutionUt Southwestern Medical Center
NIH-funded
Lab location1 site (Dallas, United States)
Project startSeptember 21, 2023
Project endAugust 31, 2028
Funding year2024
Award (this year)$451,648
NIH project number5R37CA273232-02
Project IDNIH-10932968 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients diagnosed with acute myeloid leukemia, particularly those with high-risk genetic subtypes.

Less likely to help

Patients with other types of leukemia or those who do not have acute myeloid leukemia may not benefit from this research.

What this research studies

This research investigates the mechanisms that allow leukemia stem cells (LSCs) to survive and resist treatment in acute myeloid leukemia (AML). By focusing on the regulation of protein synthesis, the study aims to identify specific genetic subtypes of LSCs that rely on this process for their self-renewal. The researchers will explore whether LSCs from high-risk types of AML are more dependent on regulated protein synthesis and will test a new therapeutic approach that targets this dependency. The ultimate goal is to develop effective therapies that can eliminate LSCs and improve patient outcomes.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that effectively target and eradicate leukemia stem cells, improving survival rates for patients with AML.

How similar studies have gone: Previous research has shown promise in targeting cancer stem cells, suggesting that this approach could lead to significant advancements in treatment.

Where this research is happening

  • Ut Southwestern Medical Center
    Dallas, United States
    Active

Researchers

  • Principal investigator: Chung, Stephen Shiu-Wah — Ut Southwestern Medical Center
  • Study coordinator: Chung, Stephen Shiu-Wah

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.